Preliminary assessment of carrageenan as excipient for extrusion/spheronisation

被引:64
作者
Bornhöft, M
Thommes, M
Kleinebudde, P [1 ]
机构
[1] Univ Dusseldorf, Inst Pharmaceut, Dusseldorf, Germany
[2] Univ Halle Wittenberg, Inst Pharmaceut & Biopharmaceut, Halle Saale, Germany
关键词
Carrageenan; microcrystalline cellulose; extrusion/spheronisation; pellet; image analysis;
D O I
10.1016/j.ejpb.2004.05.007
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The current study pursues the suitability of different types of carrageenan as a novel extrusion aid. The aim was to find Out a suitable substitution to the commonly used microcrystalline Cellulose (MCC). The types Of K-carrageenan were found to be the most appropriate material and the required fraction to produce acceptable pellets in the formulation was determined. The investigation showed that 5% of kappa-carageenan was necessary to produce pellets without MCC. Similar formulations produced with MCC or K-carrageenan were compared with respect to size and shape of the pellets. K-Carrageenan required higher water content for the formation of pellets, but the formulation was more robust as the optimal range of water content was much broader. Hence, K-Carrageenan seems to be a suitable and promising extrusion aid. The study showed that the substitution of MCC by K-carrageenan in formulations is possible and the produced pellets were of high quality. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:127 / 131
页数:5
相关论文
共 10 条
[1]
Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose [J].
Basit, AW ;
Newton, JM ;
Lacey, LF .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 1999, 4 (04) :499-505
[2]
Evaluation of bioadhesive glipizide spheres and compacts from spheres prepared by extruder/marumerizer technique [J].
Garcia, J ;
Ghaly, ES .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2001, 6 (03) :407-417
[3]
KLEINEBUDDE P, 1994, INT J PHARM, V109, P221, DOI 10.1016/0378-5173(94)90384-0
[4]
USE OF A POWER-CONSUMPTION-CONTROLLED EXTRUDER IN THE DEVELOPMENT OF PELLET FORMULATIONS [J].
KLEINEBUDDE, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (10) :1259-1264
[5]
OKADA S, 1987, CHEM PHARM BULL, V35, P761
[6]
REYNOLDS AD, 1970, MANUF CHEMIST, V41, P40
[7]
Schroder M, 1995, PHARM SCI, V1, P415
[8]
Pectinic acid, a novel excipient for production of pellets by extrusion/spheronisation: preliminary studies [J].
Tho, I ;
Sande, SA ;
Kleinebudde, P .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (01) :95-99
[9]
*US STAT PHARM CON, 2003, MON CARR, P26
[10]
VORAGEN A, 2002, POLYSACCHARIDES CARR